Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Injectco

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Injectco head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 257 · Grade C

Injectco

Visit Injectco Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Injectco a bad call — it's best for readers who want a clinic-based option and can confirm which local or virtual program, medication and package terms apply. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
69
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
72
Track Record
88
68
CoreAge RxBrief Score 94 · 65Injectco

Price, coverage & the tracker

CoreAge RxInjectco
Brief Score94/100 (A)65/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Dallas: $425/month

Or $1,800 upfront for 6–8 months; location-specific compounded program.

Separate $1,249 starting-dose GLP-1 package does not identify the drug; confirm which offer applies.

Full price details

Program quote varies by location; Dallas lists $425/month or $1,800 upfront for 6–8 months of compounded semaglutide; separate $1,249 starting-dose GLP-1 package does not identify the medication

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Dallas: $425/month

Or $1,800 upfront for 6–8 months; location-specific compounded program.

Separate $1,249 starting-dose GLP-1 package does not identify the drug; confirm which offer applies.

Full price details

Program quote varies by location; Dallas lists $425/month or $1,800 upfront for 6–8 months of compounded tirzepatide; separate $1,249 starting-dose GLP-1 package does not identify the medication

CoverageUS only; restrictions by state, confirmed at intakeTexas clinics and a Louisiana virtual program are described; complete medication-specific state eligibility is not established.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Injectco: Dallas publishes monthly and upfront options. The separate starting-dose package has different terms; get the named prescription and expected supply in writing.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.